Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes
Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
A 2-years prospective, randomized and multicentric study will be performed to assess the
efficacy of metformin compared to sitagliptin on benign thyroid nodules size ≥ 2 cm, in newly
diagnosed patients with type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Pointe-a-Pitre